Essential oils were hydrodistilled from six Zieria species, including two previously not investigated: Z. floydii and Z. odorifera subsp. williamsii, and characterized using GC-MS. Additionally, solvent extracts of leaf material from five of these species were prepared using n-hexane, acetone and methanol as solvents, respectively. These solvent extracts were examined, along with essential oils, for antibacterial activity using micro titer plate broth dilution assays. Antifungal activity against pathogenic Trichophyton species responsible for dermal infections such as Tinea and Kangaroo Pox (uncommon), was examined using a similar method. Results of essential oil characterizations are relatively consistent with those previously reported. Interestingly, the essential oil composition of Z. floydii showed car-3-en-2-one at a concentration of 71%, similar to that observed in a previous study for Z. furfuracea and Z. granulata, thus complementing the observations of A.G. Floyd that Z. floydii is morphologically allied with these two species (CANB 598758). Antimicrobial assays demonstrated relatively high antibacterial and antifungal activity, using both essential oils and solvent extracts. This is particularly true for the n-hexane extract from Z. smithii. We therefore conclude that Zieria species may be a useful source for the development of antiseptic, cosmaceutical and/or topical nutraceutical products. In addition, they may well serve as a source of further novel, purified compounds providing scaffolds for pharmaceutical development in the future.
The genus Zieria is easily recognized by its strongly aromatic, mostly trifoliolate leaves, with white or pink flowers, typically growing as a prostrate shrub, but occasionally forming into a small tree [1] . For over a hundred years, Zieria has been attracting interest with regard to its essential oils and other novel, not so pleasant products, such as the toxic cyanogenic zierin from Z. laevigata [2] .
Essential oil analysis within the Zieria genus began with Z. smithii [3, 3b] . The main components of the essential oil were elemicin, safrol and methyl eugenol. At that time, Penfold [3] was particularly concerned with taxonomic inconsistencies between Queensland and New South Wales specimens, and published results with the vision that essential oil chemovariation would trigger taxonomic reinvestigation leading to a revision of Z. smithii. Although this chemotaxonomy, per se, did not succeed in this regard, some reclassification has occurred since then.
In the latter half of the 20 th century, Zieria spp. proved to be a source for many novel essential oil compounds. Morrison et al.,
[3b] identified a novel compound from Z. smithii growing near the Bellinger River (NSW), initially called (-)-3-Δ 3 -caren-5,6-epoxide, but later revised (1956) to chrysanthenone. In turn, this revision was disputed in 1963 [1] . It is, therefore, difficult to discern if both of these compounds occur in the species, or if only chrysanthenone persists. Only chrysanthenone has been widely reported in Z. smithii in later publications [1, 1b, 5] , although it is unclear if any of these authors collected Z. smithii from the Bellinger River area.
Other novel essential oil compounds from the Zieria genus, include: zierone [6a], a sesquiterpene ketone from Z. arborescens (formerly called Z. macrophylla); car-3-en-2-one [7] , a monoterpene ketone first identified in Z. aspalathoides, but now known in several other species [1, 1b, 5] ; methoxystyrenes [8] found in essential oil from Z. smithii, Z. chevalieri and Z. arborescens ('c' type), as well as an unnamed species with affinities between Z. smithii and Z. arborescens [1] . Finally, filifolone, a monoterpene ketone, formed in an aged oil from Z. smithii, was demonstrated by Bates et al. [9] to be transformed from chrysanthenone as the oil ages.
In 1987, two exhaustive studies of the essential oils from Zieria species were published [1]. In these papers, the authors elaborated on the ramifications of the chemotaxonomic approach undertaken initially by Penfold [3] . Two approaches were thus taken. The first was focused on grouping of species or chemotypes together under a common chemical component, reflecting the dominant essential oil constituent. Using this approach, eight major essential oil chemical groups were assigned. More recently, essential oils from Zieria species have demonstrated relatively high antimicrobial activity [5] against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. MICs varied from 0.2%, v/v, to >1% and were slightly lower when major constituents were purified and re-tested.
In the current study, additional bacterial species have been screened for inhibition by five of the chemical groups from wild collections of the Zieria taxa, including groups 2 (benzaldehyde), 3.2 (safrole), 3.3 (elemicin), 4 (car-3-en-2-one), 5 (chrysanthenone) and 6.1 (monoterpene hydrocarbon dominated). These essential oils were produced and fully characterized from: Z. compacta, Z. smithii, Z. floydii, Z. odorifera subsp. williamsii and Z. obcordata. In this regard, cyanogenic compounds will be discussed later in this communication.
Location and names of Zieria species collected for screening are included in Table 2 . Results of antimicrobial activity using essential oils against five bacterial species and one species of yeast are presented in Table 3 . This activity is consistent with the activity previously reported, albeit for a smaller number of microbes [5] . Interestingly, Streptococcus pneumoniae is inhibited at a substantially lower concentration in comparison with other species tested herein, or indeed other species reported by Griffin et al. [5] . Table 4 presents the results of broth dilution tests using essential oils against pathogenic Trichophyton species responsible for Tinea (T. interdigitalis strains and T. rubrum strains) and Kangaroo Pox (T. mentagrophytes strains, taken from both a human and a kangaroo). Clearly, oils from Zieria species show exceptionally high antifungal activity in this assay. Comparisons between oils from individual species may be compromised by differential wellto-well vapor diffusion on the same plate [10] . Tables 5 and 6 present results of antimicrobial and antifungal activity, respectively, of solvent extracts of leaves of Zieria species. Solvent extracts demonstrate greater antibacterial activity than Table 6 : MIC results using solvent extracts with units mg/mL, against pathogenic Trichophyton species (Nystatin as the positive control with units µg/mL). antifungal activity. n-Hexane extracts display the highest activity, followed by acetone extracts. [11] , specifically the essential oil for odor and taste (perhaps as flavoring). This may be due to an oversight on Maiden's behalf (Maiden, 1889) [11] . However, the lack of evidence of traditional use of Zieria species, particularly Z. smithii, by Aboriginal Australian people may indicate a cultural awareness of a toxic principle that could not be safely treated with their technology.
In the 1960s, safrole was reported to be a carcinogen in rats [12a] . Being one of the most commonly reported major components in essential oils from Z. smithii, this injects a note of caution into its use, as its use may pose a potential source of toxicity to humans. In the 1970s another study showed that the secondary metabolites responsible for carcinogenic activity of safrole in rats were not produced in humans [12c] . Consequently, it is not clear whether these phenylpropanoids are truly harmful to humans. In this regard, it is possible that a specific chemotype of Eremophila longifolia, which produces essential oils predominantly made up of safrole and methyl eugenol, was in fact used medicinally by Aboriginal Australians [13] . Thus, it is likely that Aboriginal Australians were deterred from the use of Zieria species more as a consequence of the widespread occurrence of cyanogens, particularly in Z. smithii [6b], than as a consequence of the occurrence of phenypropanoids. Having said this, cases have been reported of stock poisonings and deaths occurring after ingestion of Z. smithii and Z. laxiflora, where subsequent investigations have failed to reveal the presence of hydrocyanic acid [2] . On the other hand, in other cases, cattle deaths were known to be a direct result of cyanogenic compounds present in the leaf material [6b].
It may also be worth noting that the 'd' type of Z. smithii, being the richest source of elemicin, also recorded the highest reading for cyanogenic glycosides [6b] . In this context, it would be impossible to safely utilize the hallucinogenic effects of the plant, in the absence of hydrodistillation technology.
The antimicrobial and antifungal activities of solvent extracts are not likely to have been mediated by hydrocyanic acid. A cyanogenic glucoside, zierin [2] , shown to be present in Z. laevigata, is more readily soluble in a polar solvent, such as methanol, water and, to a lesser degree, acetone, than in n-hexane, the extract of which showed the highest recorded antibacterial and antifungal activities in this study. Although it is not yet clear how widespread zierin is in the Zieria genus, hydrolysis of zierin may contribute to the biological formation of benzaldehyde, which is widespread across the Zieria genus and abundantly present in some chemotypes of Z. laevigata.
On the other hand, the first product from zierin hydrolysis would be m-hydroxybenzaldehyde. Flynn and Southwell [1] argue, therefore, that the more likely precursor to benzaldehyde would be prunasin, which is another cyanogenic glucoside similar to zierin but lacking a hydroxyl group on the potential benzaldehyde moiety. In either case, however, the cyanogenic glucoside is insoluble in apolar solvents such as n-hexane and, therefore, is not likely to contribute to contingent antimicrobial activity observed in our results. The highest antimicrobial and antifungal activity of solvent extracts was observed in the n-hexane extracts of Z. smithii and not in those from Z. compacta, which was rich in benzaldehyde and most likely to contain the above mentioned cyanogenic glucosides.
In conclusion, Zieria has demonstrated some potential with regard to bioactive essential oil constituents, and new antimicrobial compounds for further investigation. Fractionation of the n-hexane extract may yield such new and interesting antimicrobial products, or, at the very least, may further clarify the contribution, if any, of cyanogenic compounds. Characterization of essential oils identified a number of unknown compounds, such as C 10 H 14 O (A) ( Table 7) , which was present at a concentration of >10% in one case, and was detected in three-quarters of the species examined. Again, such compounds may be worthy of further investigation.
Experimental
Plant collection and hydrodistillation: Zieria specimens were collected from various endemic growing locations in New South Wales (SL100811). Corresponding voucher specimens were lodged with the N.C.W Beadle Herbarium at the University of New England, Armidale, NSW, Australia. Essential oils were extracted using hydrodistillation. Approximately 500 g of fresh foliage was removed from the twig and chopped into 0.5 mm fragments and placed into a 5 L round-bottomed flask with 2.5 L of deionized distilled water (ddH 2 0). Leaves were heated at boiling for 2-3 h by a 6 L mantle and the steam/oil mix condensed and collected in a 500 mL funnel. Oils were then separated from the hydrosol and stored in the dark at 4˚C until used.
GC-MS analysis:
Prior to GC-MS, the oils were dried to remove hydrosol emulsions (NaSO 4 ; 0.5 g in 10 mL oil) for more than 24 h. Oils were then dissolved in dichloromethane (DCM) at a ratio of 1:1000. Identification was performed by comparison of mass spectra with an electronic library database (NIST08) and confirmed using arithmetic indices [14a] , calculated relative to n-alkanes, compared with published values. Discrepancies were resolved by comparing mass spectra with those published elsewhere [14b, 14c].
Analyses were performed using a HP 6890 GC coupled to a HP 5973 mass spectrometer. Separation was accomplished with a Phenomenex ZB-5MS column (30 m x 0.25 mm i.d., 0.25 mm phase thickness). Operating conditions were as follows: Injector: split ratio 25:1; Temperature: 250˚C; carrier gas: helium, 1.0 mL/min, constant flow; column temperature, 60˚C (no hold), 3˚C per min then at 280 o hold 10 min. MS were acquired at -70 eV using a mass scan range of 45 -350 m/z. Quantification of essential oils: quantification was performed using GC coupled with flame ionization detection. The sensitivity of several authentic reference standards was calculated relative to ndecane. Equal masses of n-decane and authentic reference standard were dissolved in DCM before injection. n-Decane was then used as an internal marker for further quantification.
To prepare for analysis, equal masses of EO and n-decane were dissolved in DCM. Analyses were performed using a Varian 3300 gas chromatograph. Separation was accomplished with a Phenomenex ZB-5ms column (30 m x 0.25 mm i.d., 0.25 mm phase thickness).Operating conditions were as follows. Injector: split turned on; temperature: 250˚C; carrier gas: helium, 4.5 mL/min, constant flow; column temperature, initially 50˚C, 50-150˚C at 5˚C/min, 150˚C hold for 10 min. Working stocks of all species were maintained on nutrient agar (NA) except Candida albicans, which used yeast extract peptone agar. All growth media was purchased from Oxoid (Thebarton, South Australia) and prepared as per instructions. The minimum inhibitory concentration of the oils was determined using micro-titer Essential oils of six Zieria species Natural Product Communications Vol. 8 (6) 2013 745 plates for a serial two-fold broth dilution [15a] with the following modifications. Oil emulsions were prepared by vortexing a measured combination of oil and the appropriate broth with 0.15%, w/w, agar [15b] . Species were assayed in either Tryptone Soya Sloppy Agar (TSSB) or Yeast Extract Peptone Sloppy Agar for C. albicans, produced using the same method as described above [15b] . Broth dilutions were performed using 96-well plates.
Inoculation was achieved by collecting colonies from fresh working stocks, dispensing into 0.9%, w/v, NaCl and diluting to match a 0.5 McFarland BaSO4 Turbidity Standard [15c] using a spectrophotometer at 600 nm for bacterial suspensions or 530 nm for C. albicans. To achieve a final inoculation concentration of 5 Χ 10 5 , the adjusted saline suspension was diluted into 40 volumes of the appropriate medium, and 20 mL was used to inoculate 80 mL of assay media bringing the total volume to 100 mL and reducing the essential oil concentration to the appropriate target. Following inoculation, the 96-well plates were sealed using parafilm and placed into an incubator at 37˚C for approximately 20 h before dispensing 40 mL of sterile 0.2 mg/mL p-iodonitrotetrazolium dye, waiting for 1-4 h depending upon organism and examining visually for red color development, which indicated organism growth.
Antifungal activity: Antifungal activity was determined against 3 species of Trichophyton (sourced from the Mycology unit, Women and Children's Hospital, Adelaide) with 2 strains each: T. rubrum (granular), T. rubrum (not granular), T. mentagrophytes (sourced from Kangaroo), T. mentagrophytes (sourced from human), T. interdigitalis (Strain 1) and T. interdigitalis (strain 2). For antifungal activity, the broth dilution used mycological peptone sloppy agar in 96-well micro-titer plates and involved a serial 2 fold dilution. Sloppy agar was prepared using 0.15%, w/w, agar to achieve moderate viscosity. Inoculation was achieved by preparing a suspension of Trichophyton spores. To produce the spore suspension, working cultures of Trichophyton were propagated from pre-grown filamentous tissue every 4 days onto Saboraud agar until spore formation occurred. The suspension was prepared by collecting spores from a sporulating Trichophyton culture, using sterile cotton buds. Cotton buds were then immersed into 0.9%, w/v, saline solution and vigorously shaken to release spores into suspension. When used for inoculation, the spore suspension was diluted to match a 0.5McFarland BaSO4 turbidity standard on a spectrophotometer at 600nm. Diluted suspension was dispensed into the broth at 20% of total volume (20 mL spore solution into 100 mL broth).
The experiment was maintained at 28˚C for 4-7 days before inspection for visible signs of growth. Signs of growth were conceded if the broth had become unclear or translucent, or if the agar had a visible Trichophyton formation growing on the surface of it.
